This site is intended for US healthcare professionals only. is currently undergoing updates.
Please check back soon. Thank you for your patience.

Review and download important information for CRESEMBA® (isavuconazonium) sulfate:

Prescribing Information Patient Information

For access and reimbursement support to help patients overcome challenges to accessing CRESEMBA, visit:

CRESEMBA Patient Savings Program CRESEMBA Support Solutions

To report SUSPECTED ADVERSE REACTIONS, contact Astellas Pharma US, Inc. at 1-800-727-7003 or FDA at 1-800-FDA-1088 or